Position in KALA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$47
-$461 QoQ
Shares Held
28
-52.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 15 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in KALA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,838,661,229 across 524 Biotechnology names. KALA ranks #497 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in KALA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47 | 28 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $508 | 2,941 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $336 | 607 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $2,344 | 1,533 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $4,625 | 972 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,568 | 972 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,744 | 972 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $5,669 | 995 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $7,195 | 1,015 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $10,845 | 1,361 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $11,347 | 1,621 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $14,709 | 1,653 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $24,115 | 1,653 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $23,447 | 1,558 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $79,884 | 2,094 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $22,826 | 103,292 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,067 | 123,565 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $210,740 | 152,711 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $258,919 | 213,984 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $802,716 | 306,381 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,179,576 | 222,562 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $720,835 | 106,949 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $945,450 | 139,447 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $622,462 | 82,995 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $710,128 | 67,567 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $54,972 | 6,254 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||